株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臨床検査サービスの世界市場

Clinical Laboratory Services

発行 Global Industry Analysts, Inc. 商品コード 248889
出版日 ページ情報 英文 403 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
臨床検査サービスの世界市場 Clinical Laboratory Services
出版日: 2014年01月01日 ページ情報: 英文 403 Pages
概要

当レポートでは、臨床検査サービスの世界市場に注目し、直接取材並びに二次情報調査から得られた市場データや動向分析をもとに、2012-2020年の期間にわたる取引価額の実績と予測を地域(米国、カナダ、日本、欧州、アジア太平洋州、中南米、その他)別に提供するほか、過去6年にわたる市場の経緯や主要・精鋭参入企業164社の最新プロフィールをまとめて、概略以下の構成でお届けします。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成のレベル
    • 定量技法および分析法
  • 製品の定義と調査の範囲
    • 院内医学検査ラボ
    • その他
      • 診療所内医学検査ラボ
      • 独立検査機関
  • 第2章 エグゼクティブサマリー
  • 産業概要
    • 難局も新興市場がもたらす成長機会
    • 先進国:コスト圧力から要求される新たな施策
    • 医療サービス支出に影を落とす景気の不透明感
    • 主な成長推進要因:検証
    • 世界的な人口高齢化で増大する医療ニーズ
    • 新興市場における医療支出の増大
    • 高まる認知度
    • 医療費削減の必要性
    • 高まる疾患発生率
    • 感染症検査において拡大する臨床検査ラボの役割
    • 高難度検査市場:日常検査セグメントを上回る急成長
    • 臨床処置の意思決定において拡大する高次検査の役割
    • テーラーメイド医療および治験サービスにおける機会
    • 安定経営に向けて試薬貸出契約に活路を求める臨床検査機関
    • がん検査市場:臨床検査機関の商機
    • 入院の短期化で高まる内科検査ラボの重要性
    • 加速する検査ラボの自動化
    • 臨床検査ラボにおいて高まるITシステム利用度
    • 弾みが付く検査サービス外部委託化の傾向
    • 自己免疫疾患検査:コスト効率に優れ、生産性の高い方法を求める検査機関
    • 臨床検査機関に対するポイントオブケア検査の影響度を評価する
    • 体外診断薬(IVD)市場の成長率:臨床検査サービス市場成長の指標
    • 経済環境の趨勢に影響される検査への予算配分
    • 診療所内医学検査ラボ:短縮に向かう検査所要時間
    • ラボ検査市場が直面する課題
  • 競合環境
    • イントロダクション
    • Quest Diagnostics & LabCorp:最大手の独立検査機関
    • 依然強まる体質強化の動き
    • 代表的な臨床検査機関の買収取引(2011-2013年)
  • 臨床検査サービス - イントロダクション
    • 医学検査ラボとは
    • 医学的検査
    • 解剖病理学
    • 臨床病理学
    • 医学検査ラボで行われる検査の種類
    • 日常的検査
    • 高難度検査
    • 解剖病理学検査
    • 臨床検査ラボの種類
    • 院内医学ラボ
    • 診療所内医学ラボ
    • 参照検査ラボ
    • 医学検査ラボの潜在顧客
    • 臨床検査ラボでの作業プロセス
    • 検査ラボが追従する経済モデル
    • 収入
    • 支出
    • 医学検査ラボ業界における顧客と費用負担者の二分法
    • ラボ検査に対する環境ファクターの影響度
    • 規制概要
    • 世界的法制・規制環境
    • GCLP
    • ISO 15189:2003
    • ISO 15189 Accreditation
    • ILAC
  • 製品開発・発売
  • 最近の産業動向
  • 主要企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他の国々
  • アジア太平洋州
    • 中国
    • その他の国々
  • 中南米
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6952

This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles164 companies including many key and niche players such as -

ADICON Clinical Laboratories, Inc.
ARUP Laboratories
Asuragen, Inc.
Atherotech Diagnostics Lab
Bio-Reference Laboratories, Inc.
Clarient, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Hospital-Based Medical Laboratories
    • Others
      • Physician's Office-Based Medical Labs
      • Independent Laboratories

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Prelude
  • Despite Challenges, Emerging Markets Provide Growth Opportunities
  • Developed Nations: Cost Pressures Necessitate New Strategies
  • Economic Uncertainty Affects Spending on Healthcare Services
  • Major Growth Drivers: A Review
  • Rising Healthcare Needs of Aging Global Population
    • Table 1: Over-65 Years Population as a % of Total Population (2010 & 2020P) (includes corresponding Graph/Chart)
    • Table 2: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025) (includes corresponding Graph/Chart)
    • Table 3: Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart)
    • Table 4: Life Expectancy Rates at Birth by Geographic Region (1990 & 2011) (includes corresponding Graph/Chart)
  • Increase in Healthcare Spending in Emerging Markets
    • Table 5: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)
  • Increasing Awareness Levels
  • Need to Cut Healthcare Costs
  • Rising Incidence of Diseases
    • World Cancer Statistics: Incidence and Mortality Data
    • Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 7: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 8: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
    • Table 9: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
    • Table 10: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
    • Table 11: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
    • Table 12: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
      • Cancer Prone Sites based on Age
    • Global HIV Statistics
    • Table 13: Global Summary of the AIDS Epidemic in 2011 (includes corresponding Graph/Chart)
      • Some Significant HIV Statistics by Region (2011)
  • Increasing Role of Clinical Labs in Testing of Infectious Diseases
    • Table 14: Reported Cases of Major Infectious by Geographic Region (2011)
  • Esoteric Testing Market: Faster Growth than Routine Testing Segment
  • Increasing Role of Advanced Tests in Clinical Treatment Decision Making
  • Opportunities in Personalized Medicine and Clinical Trial Services
  • Clinical Labs Opt for Reagent Rental Contracts to Sustain Operations
  • Cancer Testing Market: Opportunity for Clinical Labs
  • Shortened Hospitalization Enhances Significance of Medical Labs
  • Lab Automation Speeds Up
  • Heightened Use of IT Systems in Clinical Laboratories
  • Laboratory Outsourcing Trend Gains Strength
  • Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options
  • Assessing the Impact of Point-of-Care Testing on Clinical Labs
  • IVD Market Growth: An Indication of Growth in Clinical Labs Market
  • Laboratory Budget Allocations Affected by Prevailing Economic Environment
  • POLs: Reducing Turnaround Times for Testing
  • Challenges Facing Lab Testing Market

2. COMPETITIVE LANDSCAPE

  • Introduction
  • Quest Diagnostics & LabCorp: The Leading Independent Labs
  • Consolidation Activity Continues to Strengthen
  • Major Clinical Laboratory Transactions (2011-2013)

3. CLINICAL LABORATORY SERVICES - AN INTRODUCTION

  • What is a Medical Laboratory?
  • Laboratory Medicine
  • Anatomic Pathology
  • Clinical Pathology
  • Types of Tests Conducted in Medical Labs
  • Routine Tests
  • Esoteric Tests
  • Anatomic Pathology Services
  • Types of Clinical Laboratories
  • Hospital-Based Laboratories
  • Physician's Office-Based Medical Labs
  • Reference Laboratories
  • Potential Customers for Medical Laboratories
  • Work Process in Clinical Labs
    • Specimen Processing & Result Analysis in Clinical Labs
    • Laboratory Information Systems
    • Conducting Lab Tests
    • Key Personnel in Medical Labs
      • Role of Medical Technologists
      • Role of Medical Technicians
    • Analysis, Validation and Interpretation of Results
    • Testing Equipment
      • Bio-Safety Hazards and Equipment Design
      • Essential Bio-safety Equipment in Clinical Laboratories
      • Personal Protection Equipment in Medical Labs
  • Economic Model Followed By Testing Laboratories
  • Revenues
  • Expenses
  • Dichotomy between Customers and Payers in Medical Lab Industry
  • Impact of Environmental Factors on Lab Tests
  • Regulatory Overview
  • Legislative & Regulatory Environment Worldwide
  • GCLP
  • ISO 15189:2003
  • ISO 15189 Accreditation
  • ILAC

4. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Genomic Health Launches Oncotype DX Prostate Cancer Test
  • Clarient Rolls Out Next-Generation Sequencing Assay
  • SilverStaff Clinical Laboratories to Provide BGM Galectin-3® Test of BG Medicine
  • Quest Diagnostics Unveils Dementia Clinical Diagnostic Panel
  • Psychemedics Unveils Hair Alcohol Test
  • Prometheus Laboratories Introduces PROMETHEUS® Anser™ ADA
  • NeoGenomics Launches Clinical Molecular Tests for MDS
  • LipoScience Introduces Vantera Clinical Analyzer for Cardiovascular Disease Management
  • Atherotech Diagnostics Lab Introduces AspirinWorks® Test
  • GeneDx to Introduce Comprehensive Genetic Tests Suite for Ovarian and Breast Cancers
  • Enzo Clinical Labs Collaborates with Oncimmune to Launch Novel Diagnostic Test
  • Myriad RBM Introduces Oncology® v. 2.0 Test
  • NeoGenomics Introduces NeoSITE™ Barrett's Esophagus FISH Test
  • diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity

5. RECENT INDUSTRY ACTIVITY

  • Quest Diagnostics Acquires Dignity Health's Clinical Operations
  • Quest Diagnostics Takes Over Laboratory Operations of Concentra
  • LifeLabs Acquires BC Biomedical
  • JLL Takes Over BioClinica and CoreLab
  • Quest Diagnostics Takes Over ConVerge Diagnostic Services
  • Spectra Laboratories Acquires Shiel Medical Laboratory
  • Gamma-Dynacare Medical Acquires Controlling Stake in Impact Genetics
  • Proove Biosciences Takes Over Colwell Clinical Labs
  • BioReference to Acquire Laboratory Business of Edge BioSystems
  • Cleveland Clinic Laboratories Signs Agreement with ACL for Specialized Testing Services
  • Cancer Genetics and Mayo Clinic Establish JV, Oncospire Genomics
  • HDL to Form Joint Venture with GeneNews for ColonSentry Test
  • Gamma-Dynacare Collaborates with OSR Medical
  • Mayo Medical and Mayo Clinic in Collaboration Agreement with bioTheranostics
  • MACL & Oncimmune® Offer EarlyCDT®-Lung Blood Test
  • Luminex and NMTC Collaborate for Lab-Developed Panel
  • ARUP Partners with Predictive Biosciences
  • PrimeraDx and Quest Diagnostics Ink Co-Development Agreement
  • DaVita Labs Inks Research Collaboration Agreement with Myriad RBM
  • Rochester General Health System Inks Partnership Agreement with Mayo Medical Laboratories
  • Corgenix Medical Inks Agreement with Atherotech Diagnostics Lab
  • MDxHealth Inks Marketing Partnership with Bostwick Laboratories
  • ARUP Laboratories Inks Agreement with Oncimmune®
  • Instituto Hermes Pardini Takes Over Diagnostika - Unidade de Patologia e Citologia
  • LifeLabs Medical Laboratory Acquires CML HealthCare
  • Mayo Medical Conducts NMR Lipoprotein Particle Testing with LipoScience Vantera® Clinical Analyzer
  • Bio-Reference Signs Agreement with Natera to Commercialize Panorama™ NIPT
  • Myriad Genetics Signs Companion Diagnostic Deal with TESARO
  • OpGen Establishes CLIA-Certified Clinical Services Laboratory and Introduces Microbial Genetic Tests for HAIs
  • Echevarne to Distribute Natera's Panorama™ Prenatal Test Panorama in Spain
  • AccelPath Acquires DigiPath
  • OPKO Health Takes Over Prost-Data
  • Ampersand Takes Over Willow Laboratories
  • LabCorp Takes Over MEDTOX
  • WCP Takes Over Sterling Reference Laboratories
  • Gamma-Dynacare to Take Over LifeLabs Quebec
  • Quest Diagnostics Takes Over S.E.D. Medical Laboratories
  • TrovaGene Acquires MultiGEN Diagnostics Clinical Laboratory Business
  • Bode Technology Group Takes Over Chromosomal Laboratories
  • Becton, Dickinson and Company Takes Over KIESTRA Lab Automation
  • CD Diagnostics Acquires Stake in CML
  • Quest Diagnostics to Acquire UMass' Clinical Laboratory Outreach Business
  • AmperSand Capital to Acquire Calloway
  • Genova Diagnostics and Metametrix Merge Operations
  • Al Borg to Merge Operations with Al Mokhtabar
  • InCyte Pathology Signs Preliminary Merger Deal with Eastside Pathology
  • Gamma-Dynacare Acquires Alcohol and Drug Testing Business of Maxxam Analytics
  • ADICON Inks Strategic Collaboration Framework Contract with Siemens
  • Myriad RBM Signs Collaboration Agreement with Sanofi and PHRI for Protein Bio-marker Research
  • DLMP and MML Collaborate with Kindstar for Esoteric Tests
  • Qiagen Signs Co-Marketing Pact with KingMed Diagnostics
  • WuXi PharmaTech Enters into JV Agreement with PRA
  • AKUH Establishes High-Tech Stat Laboratory in Rawalpindi
  • Warburg Pincus Collaborates with Lab Industry Veterans to Launch RDL
  • Covance and BML Expand CB Trial Lab
  • Bio-Reference Laboratories to Establish Laboratorio Buena Salud
  • The University of Western Australia Establishes Translational Cancer Pathology Laboratory
  • Khandelwal Laboratories Establishes KLab in Nepal

6. FOCUS ON SELECT PLAYERS

  • ADICON Clinical Laboratories, Inc. (China)
  • ARUP Laboratories (US)
  • Asuragen, Inc. (US)
  • Atherotech Diagnostics Lab (US)
  • Bio-Reference Laboratories, Inc. (US)
  • Bioscientia Institut fur Medizinische Diagnostik GmbH (Germany)
  • Clarient, Inc. (US)
  • DaVita, Inc. (US)
  • Enzo Clinical Labs (US)
  • Gaoxin - Da an Health Investment Ltd. (China)
  • Gamma-Dynacare Medical Laboratories (Canada)
  • Genoptix Medical Laboratory (US)
  • Genova Diagnostics, Inc. (US)
  • Kingmed Diagnostics (China)
  • Healthscope Ltd. (Australia)
  • Laboratory Corporation of America Holdings (US)
  • Labco S.A. (France)
  • Mayo Medical Laboratories (US)
  • Myriad Genetic, Inc. (US)
  • Pathology, Inc. (US)
  • Prometheus Laboratories, Inc. (US)
  • Quest Diagnostics, Inc. (US)
  • Sonic Healthcare Limited (Australia)
  • American Esoteric Laboratories (US)
  • Spectra Laboratories, Inc. (US)
  • Thyrocare Technologies Limited (India)
  • The National Health Laboratory Service (South Africa)
  • Unilabs SA (Switzerland)

7. GLOBAL MARKET PERSPECTIVE

    • Table 15: World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 17: World 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current and Future Analysis for Hospital-based Medical Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Hospital-based Medical Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 20: World 15-Year Perspective for Hospital-based Medical Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current and Future Analysis for Other Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Other Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 23: World 15-Year Perspective for Other Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Clinical Laboratories: A Small Yet Vital Constituent of Healthcare Industry
    • Table 24: US Healthcare Spending (2012): Percentage Share Breakdown of Spending by Segment - Hospitals, Professional Services, Prescriptions, Medical Products, Laboratory Testing, and Others (includes corresponding Graph/Chart)
      • Changing Healthcare Industry Dynamics Affect Clinical Lab Testing Market
    • Table 25: Healthcare Spending as a % of GDP (includes corresponding Graph/Chart)
    • Positive Outlook for Clinical Laboratory Services Market
      • Current and Future Analysis
    • A Glance at Major Growth Drivers
      • Unmet Diagnostic Needs of Aging Population
    • Table 26: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
    • Table 27: US Population Breakdown by Age Group (2012) (includes corresponding Graph/Chart)
      • Increasing Burden of Chronic Diseases Drives Focus onto Early Detection & Prevention
      • Cancer Statistics in the US
    • Table 28: New Cancer Cases by Gender and Affected Site in the US (2013)
      • Prevalence of Diabetes Mellitus in North America
    • Table 29: Prevalence of Diabetes Mellitus in North America (2012) (includes corresponding Graph/Chart)
      • Opportunities in Personalized Medicine and Clinical Trial Services
      • Increasing Reimbursement Pressures - Opportunities for Testing Services
      • Growing Focus on Early Diagnosis
      • Impact of Scientific Advances & Role of Healthcare IT Solutions
      • Need to Reduce Healthcare Costs
      • Legislative, Regulatory and Policy Environment
      • Opportunities for Individual Testing
      • Population Screening Initiatives
    • Challenges Facing Clinical Labs Market
    • Product-Related Trends
    • Table 30: Clinical Laboratory Testing Market in the US (2010): Percentage Share Breakdown of Revenues by Segment (includes corresponding Graph/Chart)
      • Routine Tests: The Largest Product Category
      • Anatomic Pathology & Cytology Testing: Personalized Medicine Presents Positive Future
    • Table 31: US Market for Outpatient Anatomic Pathology Testing (2010): Percentage Share Breakdown of Revenues by Test Type - Pap Smears, Skin Biopsies, Gynecology Biopsies, Prostate, Gastrointestinal, and Others (includes corresponding Graph/Chart)
      • Esoteric Testing Market: Faster Growth than Routine Testing Segment
      • Molecular Diagnostics: Promising Growth Opportunities
      • Drugs of Abuse Testing: Prospects Linked to Employment Levels
      • Future Holds Promise for Specialty Testing Market
      • Impact of Healthcare Spending Cuts on Routine & Specialty Lab Tests
      • Increasing Role of Advanced Tests in Clinical Treatment Decision Making
      • Tissue-based Diagnostics Market to Expand
      • Toxicology Laboratories Market: An Insight
      • Genetic and Genomic Clinical Lab Testing Market: Promising Prospects
    • Shift towards Managed Care - A Challenge for Independent Clinical Labs?
    • Evolving ACO Business Model: A Challenge for Independent Labs
      • Integration of Clinical Care: Impact on Clinical Labs & Anatomic Pathology Groups
    • Hospital Laboratory Outreach Programs: On the Rise
      • Physician Practices: The New Acquisition Targets
    • Table 32: % of Independent Physicians in the US (2005-2013) (includes corresponding Graph/Chart)
      • Cost Cutting Measures to Hit Lab Outreach Testing Business?
    • Hospitals Foray into Health Insurance Market: Opportunities for Hospital Labs
    • FDA to Regulate Laboratory Developed Tests (LDTs)
    • Shortened Hospital Stay Enhances Significance of Medical Labs
    • Lab Automation: A Key Trend in the Clinical Laboratory Testing Market
    • Health Plans Interpose Between Clinical Labs and Physicians
    • POCT Segment Withstands Cost Pressures
    • Dealing with Regulatory Changes: A Tough Ask for Clinical Labs
    • CMS Proposes to Slash Payment for Lab Tests
    • Providers of Clinical Laboratory Service in the US: A Review
      • Hospital-Based Labs
    • Table 33: Hospital Lab Test Market in the US (2012): Percentage Share Breakdown of Revenues by Payer (includes corresponding Graph/Chart)
    • Table 34: Registered Hospitals in the US (2012): Percentage Share Breakdown of Number of Hospitals by Type of Hospital (includes corresponding Graph/Chart)
      • Independent Labs
    • Table 35: Independent Labs Market in the US (2012): Percentage Share Breakdown of Revenues for Quest Diagnostics, LabCorp, Small Independent Labs, Niche Labs, and Tier 2 Labs (includes corresponding Graph/Chart)
      • Physician Office-Based Labs and Others
    • Competitive Landscape
      • Consolidation Activity Gathers Pace in Clinical Laboratory Testing Market
    • Table 36: Number of Closed M&A Transactions in the US Clinical Labs Market (2005-2012) (includes corresponding Graph/Chart)
    • Table 37: Closed M&A Transactions in the US Clinical Labs Market (2009-2012): Breakdown by Clinical Labs and Anatomic Pathology & Specialty Labs (includes corresponding Graph/Chart)
      • Major Clinical Laboratory Transactions (2011-2013)
    • Regulatory Landscape
      • A2LA
      • ASCLS
      • CAP
      • Clinical Laboratory Improvement Amendments (CLIA)
    • Table 38: CLIA-Certified Laboratories in the US (2013): Percentage Share Breakdown of Number of Laboratories by Certificate Type (includes corresponding Graph/Chart)
    • Table 39: CLIA-Certified Laboratories in the US (2013): Percentage Share Breakdown of Number of Labs by Lab Type (includes corresponding Graph/Chart)
      • Health Insurance Portability and Accountability Act of 1996
      • Substance Abuse and Mental Health Services Administration (SAMHSA) Regulation
    • Reimbursement Scenario for Clinical Laboratory Tests
      • Impact on Funding Changes on Clinical Labs Testing Market
      • Medicare Coverage for Screening Tests
      • Medicare Clinical Laboratory Fee Schedule (CLFS)
      • Medicare Physician Fee Schedule (MPFS)
      • Medicaid
      • Payment and Coding for Clinical Laboratory Testing Services
    • Table 40: Medicare Spending in the US (2012): Percentage Share Breakdown of Spending by Category - Inpatient Hospital, Managed Care, Prescription Drugs, Physician Fee Schedule, SNF, Home Health, Hospice, Clinical Laboratory, and Others (includes corresponding Graph/Chart)
    • Product Innovations/Introductions
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 41: US Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 42: US Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 43: US 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Chronic Diseases Spurs Need for Testing
    • Table 44: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart)
    • Table 45: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart)
    • Table 46: New Cancer Cases in Canada by Age Group and Gender (2012) (includes corresponding Graph/Chart)
    • Table 47: Prevalence of Diabetes Mellitus in Canada (2012) (includes corresponding Graph/Chart)
    • Funding Crunch Bolsters Consolidation Activity among Independent Labs
    • Regulatory Scenario in Canada
      • Accreditation Canada
      • Standards Council of Canada
    • Strategic Corporate Developments
    • Gamma-Dynacare Medical Laboratories - A Key Player
  • B. Market Analytics
    • Table 48: Canadian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 49: Canadian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 50: Canadian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Demographics Drive Market Growth
    • Table 51: Percentage Breakdown of Japanese Population by Age Group (2012) (includes corresponding Graph/Chart)
    • Table 52: Over 65 Years Population in Japan (1950-2010) (includes corresponding Graph/Chart)
    • Table 53: Prevalence of Diabetes Mellitus in Japan (2012 & 2030) (includes corresponding Graph/Chart)
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 54: Japanese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 55: Japanese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 56: Japanese 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Overview
    • Table 57: Diagnostics Market in Europe (2012): Percentage Share Breakdown of Revenues by Medical Imaging, Laboratory Testing, and Anatomic Pathology (includes corresponding Graph/Chart)
    • Debt Crisis in Europe Affects Healthcare Industry
      • European Healthcare System: In a State of Transition?
    • Aging Population to Drive Demand for Medical Laboratory Services
    • Table 58: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
    • Accreditation and Regulatory Scenario in the EU
  • B. Market Analytics
    • Table 59: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 60: European Historic Review for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 61: European 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 62: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 63: European Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 64: European 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • Overview
    • Table 65: 65+ Population as % of Total Population (includes corresponding Graph/Chart)
    • Table 66: Clinical Testing Laboratories in France (2012): Percentage Share Breakdown of Number of Labs by Type (includes corresponding Graph/Chart)
    • Labco S.A. - A Key Player
  • B. Market Analytics
    • Table 67: French Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 68: French Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 69: French 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Privatization: A Visible Trend in the Labs Market
    • Regulatory Scenario in Germany
      • DAkkS GmbH - Germany's National Accreditation Body
    • Bioscientia Institut fur Medizinische Diagnostik GmbH - A Key Player
  • B. Market Analytics
    • Table 70: German Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 71: German Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 72: German 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
    • ACCREDIA - The Italian Accreditation Body
  • B. Market Analytics
    • Table 73: Italian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Italian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 75: Italian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • UKAS - The Sole National Accreditation Body in the UK
  • B. Market Analytics
    • Table 76: UK Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 77: UK Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 78: UK 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 79: Spanish Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 80: Spanish Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 81: Spanish 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 82: Russian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 83: Russian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 84: Russian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Poland
    • Switzerland
    • Ukraine
    • Strategic Corporate Developments
    • Unilabs SA (Switzerland) - A Key Player
  • B. Market Analytics
    • Table 85: Rest of Europe Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 86: Rest of Europe Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 87: Rest of Europe 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Overview
    • Healthcare Spending in Asia-Pacific: On the Rise
    • China and India: Two Fast-Growing Markets
    • APLAC - A Regional Accreditation Body in Asia-Pacific
  • B. Market Analytics
    • Table 88: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 89: Asia-Pacific Historic Review for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 90: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 91: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 92: Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 93: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Medical Labs Market: An Overview
    • Healthcare Reforms: Opportunities for Clinical Labs Market
    • Independent Clinical Labs - A Nascent Market
    • Table 94: Leading Independent Medical Labs in China (2013): Percentage Share Breakdown of Revenues for KingMed Diagnostics, DiAn Diagnostics, Adicon Clinical Laboratories Inc., DaAn Health, and Others (includes corresponding Graph/Chart)
    • CNAL - The National Accreditation Body in China
    • HKAS - An Accreditation Body in Hong Kong
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 95: Chinese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 96: Chinese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 97: Chinese 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Review of Select Regional Markets
      • Australia
      • Strong Growth in Lab Testing Leads to Increased Private Health Insurance Premiums
      • NATA - An Australian Regulatory Agency
      • India
      • Clinical Laboratory Market: Overview
      • Growth Drivers
      • Challenges
    • Table 98: Indian Medical Laboratories Market (2010): Percentage Share Breakdown of Revenues by Type of Lab - High-End Labs, Regional Labs, and Manual Labs (includes corresponding Graph/Chart)
    • Table 99: Indian Clinical Laboratory Market (2013E): Percentage Share Breakdown of Revenues by Segment - Biochemistry, Immunology, Hematology, Microbiology, Histopathology, Molecular, and Genetics (includes corresponding Graph/Chart)
      • Biochemistry Analysis: An Important Clinical Lab Segment
      • Competitive Landscape
      • Business Model of Medical Labs
    • Table 100: Indian Medical Laboratories Market (2013)): Number of Labs and Collection Centers Operated by Metropolis, SRL Diagnostics, and Dr. Lal Path Labs
      • Regulatory Scenario in India
      • Indonesia
      • Korea
      • Rapidly Aging Population Spurs Demand for Clinical Lab Testing
    • Table 101: South Korean Medical Laboratories Market (2010): Percentage Share Breakdown of Medical Laboratories by Healthcare Segment - Immunochemistry, Infectious Disease, Clinical Chemistry, Microbiology, Hematology, Molecular Biology, and Others (includes corresponding Graph/Chart)
      • KOLAS - The National Accreditation Agency of Korea
      • Philippines
      • Regulatory Scenario in Philippines
      • Singapore
      • SAC - The National Agency for Accreditation in Singapore
      • Thailand
      • BLQS - A Designated Accreditation Authority in Thailand
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 102: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 103: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 104: Rest of Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Brazil
      • Overview
    • Table 105: Anatomic Pathology Test Labs in Brazil (2012): Percentage Share Breakdown of Number of Labs by Region (includes corresponding Graph/Chart)
      • INMETRO - The National Accreditation Body of Brazil
    • Chile
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 106: Latin American Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 107: Latin American Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 108: Latin American 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Medical Laboratories in Sub-Saharan Africa
    • East Africa
    • West Africa
    • Nigeria
    • South Africa
      • Regulatory Environment in South Africa
    • Strategic Corporate Development
    • The National Health Laboratory Service (South Africa) - A Key Player
  • B. Market Analytics
    • Table 109: Rest of World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 110: Rest of World Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 111: Rest of World 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top